# Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/diminished-efficacy-of-programmed-death-ligand-1-inhibition-in-stk11-and-keap1/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Biagio Ricciuti,Kathryn C. Arbour,W. Marston Linehan,Amir Vajdi,Natalie I. Vokes,Lingzhi Hong,Jianjun Zhang,Michael Tolstorukov,Yvonne Y. Li,Liam F. Spurr,Andrew D. Cherniack,Gonzalo Recondo,Giuseppe Lamberti,Xinan Wang,Deepti Venkatraman,Joao V. Alessi,Victor R. Vaz,Hira Rizvi,Jacklynn V. Egger,Andrew J. Plodkowski,S. Khosrowjerdi,Subba R. Digumarthy,Hyesun Park,Nuno Vaz,Mizuki Nishino,Lynette M. Sholl,David A. Barbie,Mehmet Altan,John V. Heymach,Ferdinandos Skoulidis,Justin F. Gainor,Matthew D. Hellmann,Mark M. Awad |
| Citations | 378 |
| DOI | 10.1016/j.jtho.2021.10.013 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/10980559 |
| OpenAlex ID | https://openalex.org/W3136351248 |
| PMID | 34740862 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Biagio Ricciuti](https://scholariq.org/researchers/biagio-ricciuti/)
- [Matthew D. Hellmann](https://scholariq.org/researchers/matthew-d-hellmann/)
- [John V. Heymach](https://scholariq.org/researchers/john-v-heymach/)
- [David A. Barbie](https://scholariq.org/researchers/david-a-barbie/)
- [Mizuki Nishino](https://scholariq.org/researchers/mizuki-nishino/)
- [Justin F. Gainor](https://scholariq.org/researchers/justin-f-gainor/)
- [Natalie I. Vokes](https://scholariq.org/researchers/natalie-i-vokes/)
- [Lynette M. Sholl](https://scholariq.org/researchers/lynette-m-sholl/)
- [Jianjun Zhang](https://scholariq.org/researchers/jianjun-zhang-2/)
- [Michael Tolstorukov](https://scholariq.org/researchers/michael-tolstorukov/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.